People · Operator
Named in public records as an officer, director or promoter · active 2009–2010 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| CardioGenics Inc. | — | Biotechnology | Seed | $2.7M | $120.6M | 2009 |
| CardioGenics Holdings Inc. | — | Biotechnology | Seed | $1.9M | $85.1M | 2010 |
J. Neil Tabatznik at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside J. Neil Tabatznik on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| James Essex | 2 | 2 |
| Yahia Gawad | 2 | 2 |
| CHANDRA PANCHAL | 1 | 2 |
| Linda DG Sterling | 1 | 1 |
| Alexander DG Reid | 1 | 1 |
| David Carville | 1 | 1 |
| Alexander Reid | 1 | 1 |
| Linda J. Sterling | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.